mHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare
•Download as PPTX, PDF•
0 likes•153 views
The document discusses the medical devices market in Portugal. It notes that the market size is around 1,200 million Euros per year and is very import-dependent. The main challenges facing the market are the emphasis on lowest price in public contracts which limits innovation, bureaucracy in public procurement, and the need for continuous equipment updates and staff training. Opportunities exist for high-quality, efficient devices that can help reduce health care costs. GE Healthcare aims to create value through services around its large installed base of equipment.
Recommended
Recommended
More Related Content
What's hot
What's hot (19)
Similar to mHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare
Similar to mHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare (20)
More from Levi Shapiro
More from Levi Shapiro (20)
Recently uploaded
Recently uploaded (20)
mHealth Israel_Medical Devices in Portugal_Rui Costa_GE Healthcare
- 1. Medical Devices in Portugal DAN Content approved for internal and external use. Rui Costa General Manager GE Healthcare Portugal 02 July 2020
- 2. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. GE Healthcare - A leading global medtech and diagnostics innovator, at the center of an ecosystem striving for precision health Precision Health Capacity 160 million people entering the middle class each year1 Productivity $500+ million of wasted healthcare spend per year in U.S; 20% healthcare spend wasted across OECD countries2 Patient Outcome s Medical errors estimated to be the 3rd leading cause of death3 1 Kharas, Brookings Institution, 2017 2 Berwick and Hackbarth, JAMA, 2012; OECD 2017 3 Makary and Daniel, BMJ, 2016 Healthcare that is integrated, efficient and personalized to each patient
- 3. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Focused on solutions for diagnosis, treatment and monitoring Imaging • MR • CT • MI • X-Ray • Women’s Health • Image Guided Therapies Ultrasound • Women’s Health • Cardiovascular • General Radiology • Point of Care • Primary Care Life Care Solutions • Monitoring • Anesthesia & Respiratory • Diagnostic Cardiology • Maternal & Infant Care Enterprise Digital Solutions • PACS/RIS • VNA • Advanced Visualization • CVIT • Contrast Media • Molecular Imaging Agents GE Healthcare Partners GE Healthcare Equipment Finance EdisonTM Intelligence Platform Business lines* Offerings Capabilities Nine Commercial Regions One Integrated Supply Chain Global Services Pharmaceutical Diagnostics
- 4. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. What is a Medical Device? ‘Medical device’ means any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination, for human beings, for one or more of the specific medical purpose(s) of: •diagnosis, prevention, monitoring, treatment or alleviation of disease, •diagnosis, monitoring, treatment, alleviation of or compensation for an injury, •investigation, replacement, modification, or support of the anatomy or of a physiological process, •supporting or sustaining life, •control of conception, •disinfection of medical devices •providing information by means of in vitro examination of specimens derived from the human body; and does not achieve its primary intended action by pharmacological, immunological or metabolic means, in or on the human body, but which may be assisted in its intended function by such means. Source: WHO, https://www.who.int/medical_devices/full_deffinition/en/
- 5. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Global Landscape Source: Healthcare Resourse Guide: Portugal updated November 2019; export.gov
- 6. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. The Medical Devices market in Portugal is around 1200 M€/year Source: Healthcare Resourse Guide: Portugal updated November 2019; export.gov
- 7. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Current Trends • The Portuguese market for medical equipment is mature and presents a high level of sophistication. • Portuguese are educated consumers and expect state-of-the-art medical treatment, which ensures continuous demand for innovative medical equipment and products. • One of the prime characteristics of this market is its high level of imports. Total annual expenditures for new equipment are determined in the annual budgets of hospitals. These budgets are prepared according to estimates based on the previous year. • High quality and technically sophisticated medical equipment have the best market potential in Portugal, especially equipment that increases efficiency and reduces occupancy rates in hospitals. • In Portugal, imports are a fundamental component of the medical equipment market. Major suppliers are the U.S., Germany, France, Japan and China.
- 8. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Main Challenges - Reflections 1. “Lowest price” criteria in public contracts limits the access to innovation 2. Bureaucracy in public contracting, several public contracting platforms, long time to take decisions 3. Training/capacitation of clinical and technical staff on the use of the medical equipment 4. Continuous update & renewal of old and obsolete installed base
- 9. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Main Challenges - Reflections 5. Maintenance, obsolescence, reduction in budgets for maintenance contracts 6. Debt from public sector still (very)high, although improving Source: APORMED, https://www.apormed.pt/index.php/prioridades/divida-hospitalar
- 10. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Initial purchase End-of life Financing Break-fix services and parts Accessories Consumables Customer training Consultative services Managed Equipment Services Contract Maintenance Services Ultrasound Probes MR and X-Ray Contrast Agents Customer Training and Education Hospital Command Center Imaging Insights Apps and tech-enabled services Creating value through the world’s largest installed base
- 11. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Technology InnovatorsIndustry InnovatorsIndustry InnovatorsClinical Innovators Collaborating with partners across the healthcare ecosystem
- 12. Confidential and internal. Not to be copied, distributed, or reproduced without prior approval. Connect with us LinkedIn www.linkedin.com/company/gehealthcar e Facebook www.facebook.com/GEHealthcare Website www.gehealthcare.com Instagram www.instagram.com/gehealthcare Twitter www.twitter.com/GEHealthcare Newsroom newsroom.gehealthcare.com
Editor's Notes
- Healthcare as a whole is moving towards precision health: an approach to care that is integrated, efficient and highly personalized to each patient. The scale and breadth of our portfolio, along with our digital capabilities, uniquely positions us at the center of this ecosystem striving for precision health. Our goal is to deliver increased capacity, improved productivity, and better patient outcomes for our customers. These are key challenges to overcome to support the delivery of precision health.
- We are organized into several business lines, each of which is used in the diagnosis, treatment and monitoring of patients: Imaging: Magnetic resonance, computed tomography, molecular imaging, x-ray systems and complementary software and services, for use in general diagnostics, Women’s Health and image-guided therapies; Ultrasound: High-frequency soundwave systems, and complementary software and services, for use in diagnostics tailored to a wide range of clinical settings; Life Care Solutions (“LCS”): Clinical monitoring and acute care systems, and complementary software and services, for use in intensive care, anesthesia delivery, diagnostic cardiology and perinatal care; Enterprise Digital Solutions (“EDS”): Enterprise digital, consulting and healthcare technology management offerings designed to improve efficiency in healthcare delivery and expand global access to advanced healthcare; and Pharmaceutical Diagnostics (“PDx”): Contrast media and molecular imaging agents used to enhance the acuity of diagnostic imaging. GE Healthcare has a leading global position in each of these business lines. Our portfolio meets a broad range of customer needs and comprises premium lines that cater to care innovators, academic institutions and leading hospital systems, mid-tier lines that cater to hospitals, clinics and private practices, and affordable care solutions designed for healthcare systems in emerging markets. All five business lines share a common horizontal capability in go-to-market, supply chain and digital platforms, bringing efficiencies and scale to their global efforts. We also complement our products with maintenance services and additional solutions that bring value to our customers, including digital solutions such as advanced visualization and workflow management, managed equipment services, financing solutions, customer and end-user training, and enterprise-wide consulting.
- We continuously bring value to our customer installed base through a broad range of offerings that include financing, maintenance services and parts, accessories and consumables, and other services such as customer education, consulting and digital applications. This broad portfolio and business model offer continuous value for customers. One example of this strength is our services business, which is larger than any of our competitors. We deliver our service offerings through over 9,000 field service engineers, 31 global repair centers and 43 customer service centers. In 2018, we resolved over 70% of service issues on the first call, and we manage an average of over 3,200 parts orders per day. We offer both traditional services for installation, warranty and maintenance, and digital services for real-time remote monitoring, data analytics and specialized support applications. Currently, over 80% of our imaging systems are connected for remote monitoring, enabling diagnostic consultations with skilled, off-site engineers, predictive maintenance and asset management analytics.
- To create these solutions, we will work with the evolving ecosystem of clinical, industry and technology innovators. We already have many partnerships in place today, ranging from the development of cutting-edge artificial intelligence algorithms with leading academic innovators to joining forces with Roche Diagnostics. This partnership combines our leading in-vivo diagnostics portfolio with Roche’s leading in-vitro diagnostics portfolio to provide a complete, 360-degee view of a patient’s diagnostic data -- an essential factor in complex diseases such as cancer or sepsis. We are also working with the leading technology innovators to harness their advances in cloud, artificial intelligence and cybersecurity for precision health.